News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
687,683 Results
Type
Article (39141)
Company Profile (282)
Press Release (648260)
Section
Business (203905)
Career Advice (1996)
Deals (35371)
Drug Delivery (89)
Drug Development (80848)
Employer Resources (168)
FDA (16097)
Job Trends (14806)
News (344639)
Policy (32450)
Tag
Academia (2531)
Alliances (49178)
Alzheimer's disease (1256)
Approvals (16040)
Artificial intelligence (144)
Bankruptcy (352)
Best Places to Work (11576)
Biotechnology (200)
Breast cancer (188)
Cancer (1352)
Cardiovascular disease (110)
Career advice (1664)
Cell therapy (274)
Clinical research (64655)
Collaboration (467)
Compensation (255)
COVID-19 (2541)
C-suite (108)
Data (1371)
Diabetes (167)
Diagnostics (6168)
Earnings (84889)
Employer resources (146)
Events (109981)
Executive appointments (382)
FDA (16743)
Funding (420)
Gene therapy (195)
GLP-1 (594)
Government (4332)
Healthcare (18689)
Infectious disease (2632)
Inflammatory bowel disease (111)
Interviews (309)
IPO (16330)
Job creations (3625)
Job search strategy (1418)
Layoffs (416)
Legal (7861)
Lung cancer (197)
Manufacturing (199)
Medical device (13210)
Medtech (13215)
Mergers & acquisitions (19186)
Metabolic disorders (442)
Neuroscience (1571)
NextGen Class of 2024 (6500)
Non-profit (4467)
Northern California (1673)
Obesity (254)
Opinion (183)
Patents (116)
People (56437)
Phase I (20108)
Phase II (28474)
Phase III (21228)
Pipeline (511)
Postmarket research (2560)
Preclinical (8546)
Radiopharmaceuticals (236)
Rare diseases (256)
Real estate (5890)
Regulatory (21644)
Research institute (2311)
Resumes & cover letters (349)
Southern California (1447)
Startups (3562)
United States (14988)
Vaccines (562)
Weight loss (179)
Date
Today (136)
Last 7 days (559)
Last 30 days (2538)
Last 365 days (35280)
2024 (34782)
2023 (40077)
2022 (51178)
2021 (55710)
2020 (54086)
2019 (46541)
2018 (35019)
2017 (32110)
2016 (31480)
2015 (37552)
2014 (31318)
2013 (26345)
2012 (28570)
2011 (29265)
2010 (27328)
Location
Africa (713)
Arizona (194)
Asia (37248)
Australia (6082)
California (3762)
Canada (1432)
China (297)
Colorado (170)
Connecticut (175)
Europe (79788)
Florida (529)
Georgia (133)
Illinois (379)
Indiana (223)
Kansas (96)
Maryland (620)
Massachusetts (2934)
Michigan (170)
Minnesota (287)
New Jersey (1084)
New York (1066)
North Carolina (736)
Northern California (1673)
Ohio (145)
Pennsylvania (914)
South America (1091)
Southern California (1447)
Texas (541)
Utah (105)
Washington State (396)
687,683 Results for "viacyte inc".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Business
Vertex’s Viacyte Backs Out of CRISPR Diabetes Deal
Vertex still has an ongoing diabetes partnership with CRISPR, which gives it a non-exclusive license to the latter’s platform to develop a potential cure for type 1 diabetes.
January 9, 2024
·
2 min read
·
Tristan Manalac
Drug Development
CRISPR/ViaCyte and Genprex Vie for First Diabetes Gene Therapy
Partners CRISPR and ViaCyte (Vertex), and Genprex are pioneers in the quest to develop a gene therapy for Type 1 diabetes.
March 10, 2023
·
3 min read
·
Jia Jie Chen
Press Releases
ABS Bio, Inc. announces strategic investment by 3 Boomerang Capital
◆Investment to support services growth. ◆Industry veterans join board of directors, including John Chickosky as Executive Chairman, and Greg Swanberg and Martin LeBlanc as Directors.
November 14, 2024
·
1 min read
Deals
Vertex Buys ViaCyte in Synergistic Deal Aimed at Curing Type 1 Diabetes
Vertex Pharmaceuticals plans to acquire ViaCyte for $320 million in cash. ViaCyte focuses on stem cell-derived cell replacement therapies that they hope will cure type 1 diabetes (T1D).
July 11, 2022
·
3 min read
·
Mark Terry
Press Releases
TuHURA Biosciences, Inc. Enters into Definitive Merger Agreement to Acquire Kineta, Inc.
December 12, 2024
·
19 min read
Press Releases
BRIJ Medical, Inc. Awarded Breakthrough Technology Agreement in the Non-Invasive Skin Closure Category with Premier, Inc.
December 17, 2024
·
2 min read
Press Releases
Poseida Therapeutics, Inc. Announces Agreement to be Acquired by Roche Holdings, Inc.
November 26, 2024
·
9 min read
Press Releases
Scott Burger Appointed as CEO of AngioInsight, Inc.
December 17, 2024
·
2 min read
Biotech Beach
ViaCyte to Participate in 2022 Advanced Technologies & Treatments for Diabetes Conference
Manasi Sinha Jaiman, M.D., M.P.H., who was recently appointed Chief Medical Officer at Viacyte Inc., will participate in the 15th International Conference on Advanced Technologies & Treatments for Diabetes’ (ATTD) session, Utility of PROs in Therapy Development for Type 1 Diabetes: Putting the End-User Upfront.
April 20, 2022
·
2 min read
Business
ViaCyte Appoints Marty Lorenzo as General Counsel
ViaCyte, Inc., a clinical-stage regenerative medicine company developing novel cell replacement therapies to address diseases with significant unmet needs, announced the appointment of Marty Lorenzo as General Counsel.
November 30, 2021
·
2 min read
1 of 68,769
Next
